Medx Health (TSXV:MDX) LT-Debt-to-Total-Asset : 1.14 (As of Sep. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Medx Health LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Medx Health's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 1.14.

Medx Health's long-term debt to total assets ratio declined from Sep. 2023 (1.26) to Sep. 2024 (1.14). It may suggest that Medx Health is progressively becoming less dependent on debt to grow their business.

Medx Health LT-Debt-to-Total-Asset Historical Data

The historical data trend for Medx Health's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medx Health LT-Debt-to-Total-Asset Chart

Medx Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.32

3.27

1.22

1.28

Medx Health Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															1.26	1.28	1.31	1.12	1.14

Medx Health LT-Debt-to-Total-Asset Calculation

Medx Health's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0.882	/	0.69
	=	1.28

Medx Health's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	0.996	/	0.876
	=	1.14

Medx Health (TSXV:MDX) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Medx Health LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Medx Health's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Medx Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medx Health Corp (TSXV:MDX) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

1495 Bonhill Road, Unit 1, Mississauga, ON, CAN, L5T 1M2

Website

https://www.medxhealth.com

Medx Health Corp is engaged in the development, manufacturing, and marketing of skin-related screening tools and phototherapy devices for pain relief and tissue repair. Its two main product lines are; SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and Phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It derives key revenue from the sale of Phototherapeutic lasers. The company sells its products internationally, of which prime revenue is generated in Canada and the United States.

Executives

Edmund Ho	Director
Stephen Owen Lockyer	Director
David John Hennigar	Director
Luigi Canitano	Senior Officer
Gary Norman Van Nest	Director

Medx Health Headlines

No Headlines